Filtered By:
Source: Annals of Allergy, Asthma and Immunology
Condition: SARS
This page shows you your search results in order of date.
Order by Relevance | Date
Total 56 results found since Jan 2013.
Preference for and Impact of Telehealth vs. In-person Asthma Visits Among Black and Latinx Adults
CONCLUSION: TH may be similarly efficacious as and often preferred over IP among Black and Latinx adults with moderate-severe asthma, especially for regular checkups.PMID:37490981 | DOI:10.1016/j.anai.2023.07.012
Source: Annals of Allergy, Asthma and Immunology - July 25, 2023 Category: Allergy & Immunology Authors: Israel C Ugalde Amanda Ratigan Conner Merriman Jing Cui Brianna Ericson Paula Busse Jennifer K Carroll Thomas Casale Juan Carlos Celed ón Tamera Coyne-Beasley Maureen Fagan Anne L Fuhlbrigge Gabriela Gaona Villarreal Paulina Arias Hernandez Sunit Jariwal Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417-9. doi: 10.1016/j.anai.2023.06.009. Online ahead of print.NO ABSTRACTPMID:37321447 | DOI:10.1016/j.anai.2023.06.009
Source: Annals of Allergy, Asthma and Immunology - June 15, 2023 Category: Allergy & Immunology Authors: Iris Kim Tricia Morphew Christine Chou Louis Ehwerhemuepha Stanley Galant Source Type: research
The Role of IL-13 and the Type 2 Immune Pathway in COVID-19: A Review
Ann Allergy Asthma Immunol. 2023 Mar 14:S1081-1206(23)00172-2. doi: 10.1016/j.anai.2023.03.009. Online ahead of print.ABSTRACTWhile much has been learned about SARS-CoV-2 since December of 2019, uneven global vaccine distribution, rapid viral spread and variant evasion of preventative measures has led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to significant morbidity and mortality. Data demonstrating the involvement of type 2 immune pathway in acute COVID-19 and post recover...
Source: Annals of Allergy, Asthma and Immunology - March 16, 2023 Category: Allergy & Immunology Authors: Jennifer Sasson G Brett Moreau William A Petri Source Type: research
Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency
CONCLUSION: Our results suggest that patients with CVID may have impaired antibody responses to COVID-19 vaccination but intact T-cell responses, while patients with SAD would be expected to have both intact antibody and T-cell responses to vaccination.PMID:36736722 | PMC:PMC9891791 | DOI:10.1016/j.anai.2023.01.025
Source: Annals of Allergy, Asthma and Immunology - February 3, 2023 Category: Allergy & Immunology Authors: Jamie A Rosenthal Michelle Premazzi Papa Marta Sanz Samuel Nicholes Carissa Stower Alberto Bosque Anjeni Keswani Richard Amdur Rebecca M Lynch Natalia Soriano-Sarabia Daniel Ein Source Type: research
Present and Future: Infectious Tropical Travel Rashes and the Impact of Climate Change
Ann Allergy Asthma Immunol. 2022 Dec 24:S1081-1206(22)02010-5. doi: 10.1016/j.anai.2022.12.025. Online ahead of print.ABSTRACTIn this paper, we discuss pertinent cutaneous findings that patients may present following travel to tropical destinations. We address arthropod-borne infectious diseases such as Cutaneous Leishmaniasis, Chagas Disease, Cutaneous Larvae Migrans, Myiasis, and others. We discuss other relevant diseases with cutaneous signs such as Monkey Pox and SARS-CoV-2. We provide clinicians with information regarding the background, diagnosis, treatment, and prevention of these tropical rashes. Additionally, we a...
Source: Annals of Allergy, Asthma and Immunology - December 27, 2022 Category: Allergy & Immunology Authors: James E Dinulos James G Dinulos Source Type: research
Impact of Vaccination against SARS-CoV-2 on the Atopic Dermatitis Serum Proteome
Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01988-3. doi: 10.1016/j.anai.2022.12.006. Online ahead of print.NO ABSTRACTPMID:36509406 | DOI:10.1016/j.anai.2022.12.006
Source: Annals of Allergy, Asthma and Immunology - December 12, 2022 Category: Allergy & Immunology Authors: Madeline Kim Benjamin Ungar Yeriel Estrada Ana B Pavel Emma Guttman-Yassky Source Type: research
COVID-19 patients are characterized by dysregulated levels of membrane and soluble CD48
CONCLUSION: Considering the changes of mCD48 and sCD48, a role for CD48 in COVID-19 can be assumed and needs to be further investigated.PMID:36280100 | DOI:10.1016/j.anai.2022.10.009
Source: Annals of Allergy, Asthma and Immunology - October 24, 2022 Category: Allergy & Immunology Authors: Hadas Pahima Ilan Zaffran Eli Ben-Chetrit Amir Jarjoui Pratibha Gaur Maria Laura Manca Dana Reichmann Efrat Orenbuch-Harroch Ekaterini Tiligada Ilaria Puxeddu Carl Zinner Alexandar Tzankov Francesca Levi-Schaffer Source Type: research
